# تقرير تدقيق الأساسات العميق - ZILFIT - 2026-05-13

## 1. الملخص التنفيذي
هذا التقرير يراجع أساس مشروع ZILFIT من زاوية المستودع، الوكلاء، التقارير، الحدود غير الطبية، وجاهزية الأساس التشغيلي. التحقق السريري لا يزال بانتظار مراجعة متخصصين.

## 2. حالة المستودع الحالية
?? queue/deep_foundation_audit_request.md
?? reports/daily/2026-05-13_deep_foundation_audit.md

## 3. آخر التغييرات
311ca1c reports: add manual daily review report and runner
d03a2c4 scripts: add manual daily review runner
d601a4e queue: add reusable next daily review request
c28176c reports: add daily queue review report
aca422d reports: add queue daily review report
92d1f16 docs: add daily review queue request
23fdb00 docs: add ZILFIT operating queue templates
61c7afa docs: add clinical specialist protocol draft
ad0508a chore: ignore local aider session files
6d6237a docs: add ZILFIT agent roster and model policy

## 4. الملفات المرجعية المقروءة
- governance/AGENT_ROSTER.md
- governance/CLINICAL_SPECIALIST_PROTOCOL_DRAFT.md
- queue/README.md
- queue/daily_review_template.md
- reports/daily/*.md الأحدث فقط

## 5. تقييم نظام الوكلاء
# ZILFIT Agent Roster

Status: official working roster  
Scope: agent classification, skill ownership, model budget policy, and execution boundaries.

## 1. Active Daily Agents

| Agent | Purpose | Runtime JSON | Role File | Skill File | Use | Do Not Use For | Model Tier |
|---|---|---|---|---|---|---|---|
| Z-Ops | daily operation, reports, runtime health, workflow hygiene | yes | partial/implicit | governance / operational docs | daily reports, status checks, agent health | product claims, medical review, CAD generation | cheap |
| Z-QA | validation, tests, diff review, evidence integrity | yes | partial/implicit | quality / governance docs | JSON validation, test review, changed-file review | unsupervised product decisions | cheap / manual-shell |
| Z-Research | open-access research intake and source organization | yes | yes/agents/research | research/governance docs | literature intake, source summaries | medical claims or clinical conclusions | cheap / medium |
| Z-Product | product direction and sample-readiness priority | yes | partial/implicit | product/governance docs | prioritization, sample-readiness framing | direct engineering calculations without specialist agents | cheap / medium |
| Z-Claims | non-medical claims guardrail | yes | partial/implicit | governance/Z_CLAIMS_SKILLS.md | block diagnosis, treatment, prevention, pain-relief claims | replacing clinical/specialist review | cheap / Claude-Sonnet-only for sensitive claims |

## 2. Engineering On-Demand Agents

| Agent | Purpose | Runtime JSON | Role File | Skill File | Use | Do Not Use For | Model Tier |
|---|---|---|---|---|---|---|---|
| Z-Bio | plantar biomechanics and gait-signal interpretation for engineering | yes | agents/z_bio/AGENT_ROLE.md | governance/Z_BIO_SKILLS.md | pressure zones, gait phase, engineering-only biomechanics | diagnosis, treatment, clinical efficacy | medium / Claude-Sonnet-only when sensitive |
| Z-Physics | load, pressure, wall thickness, lattice and safety-factor reasoning | yes | agents/z_physics/AGENT_ROLE.md | governance/Z_PHYSICS_SKILLS.md | load cases, wall thickness estimates, engineering assumptions | final safety certification without physical/FEA validation | medium / Claude-Sonnet-only |
| Z-Printability | STL/3MF print feasibility and pre-flight checks | yes | agents/z_printability/AGENT_ROLE.md | governance/Z_PRINTABILITY_SKILLS.md | mesh readiness, overhangs, wall thickness, supports | medical or product claims | medium |
| Z-CAD | CAD handoff and parametric geometry planning | yes | future/partial | governance/Z_CAD_SKILLS.md | converting evidence into CAD requirements | uncontrolled product expansion | Claude-Sonnet-only |
| Z-Sim | simulation and FEA readiness | yes | future/partial | governance/Z_SIM_SKILLS.md | FEA plan, simulation assumptions, validation requirements | replacing physical tests | Claude-Sonnet-only |

## 3. Specialist / Future Agents

| Agent | Purpose | Runtime JSON | Role File | Skill File | Status | Model Tier |
|---|---|---|---|---|---|---|
| Z-FemmeBiomech | female-specific biomechanics review layer | unknown/future | not confirmed | governance/Z_FEMMEBIOMECH_SKILLS.md | future specialist layer | medium / specialist |
| Z-NeuroFoot | neurological foot/gait specialist review layer | unknown/future | not confirmed | governance/Z_NEUROFOOT_SKILLS.md | future clinical/specialist layer | specialist |
| Z-PsyFoot | behavioral or psychological foot-use context | unknown/future | not confirmed | governance/Z_PSYFOOT_SKILLS.md | future/low priority | cheap / delay |
| Z-Guide | user guidance and explanatory layer | unknown/future | not confirmed | governance/Z_GUIDE_SKILLS.md | future support layer | cheap |
| Z-UX / Z-Camera-UX | UX and camera-flow guidance | partial/future | not confirmed | governance/Z_UX_SKILLS.md | use only for UX tasks | do not mix with engineering validation | cheap / medium |
| Z-Patent | patent/IP framing and prior-art support | partial/future | not confirmed | governance/Z_PATENT_SKILLS.md | prior-art, invention framing, filing packet support | legal filing without professional review | Claude-Sonnet-only / human review |

## 4. Role / Skill Mapping Policy

- Runtime JSON means the agent is represented in runtime health tracking.
- AGENT_ROLE.md means the agent has a direct prompt or role instruction.
- Governance skill files define what an agent can evaluate or produce.
- A skill file alone does not mean the agent should run daily.
- Future/specialist agents must not consume daily budget unless Sultan explicitly requests that layer.

## 5. Alias Policy

Use these canonical mappings:

| Alias | Canonical |
|---|---|
| Z-Clm | Z-Claims |
| Z-Des | Z-Design |
| Z-Prod | Z-Product |
| Z-Res | Z-Research |
| Z-UX | Z-Design or Z-Camera-UX depending on context |
| Engineering Review | engineering_review |
| Handoff Writer | handoff_writer |
| Quality Gate | quality_gate |
| Orchestrator | orchestrator |

Aliases should not be treated as new agents unless a separate runtime JSON, role file, and skill file exist.

## 6. Medical / Clinical Boundary

ZILFIT may support future specialist review by orthopedic, neurological, biomechanics, and clinical reviewers.

Product-facing outputs must not claim:
- diagnosis
- treatment
- prevention
- pain relief
- clinical efficacy
- correction of gait pathology
- therapeutic outcome

Allowed current framing:
- engineering estimate
- design guidance
- pressure-zone assumption
- load-case estimate
- printability check
- simulation requirement
- specialist review required
- clinical validation pending

Clinical or medical review must be separated into a future specialist protocol and must not be mixed into public product claims.

## 7. Budget / Model Policy

| Task Type | Model Tier |
|---|---|
| file reading, inventories, summaries, daily reports | cheap |
| JSON validation, git status, git diff, py_compile | manual-shell |
| non-sensitive governance docs | cheap |
| evidence review and engineering reasoning | medium |
| source-code edits, architecture changes, claims/legal-sensitive text | Claude-Sonnet-only |
| CAD/FEA planning and production-sample decisions | Claude-Sonnet-only + human approval |
| medical/clinical specialist material | specialist/human review required |

## 8. Daily Operating System Recommendation

Daily:
- Z-Ops
- Z-QA
- Z-Research
- Z-Product
- Z-Claims

On demand for sample readiness:
- Z-Bio
- Z-Physics
- Z-Printability
- Z-CAD
- Z-Sim

Future/specialist:
- Z-FemmeBiomech
- Z-NeuroFoot
- Z-PsyFoot
- Z-Guide
- Z-UX / Z-Camera-UX
- Z-Patent

## 9. Execution Boundaries

Do not modify:
- demo
- Telegram bot
- proxy
- API keys
- auth
- cron
- systemd
- production tunnels
- main branch

Do not delete files.

Do not commit without Sultan approval.

All changes must be small, explained, tested, and reviewed before commit.

## 6. تقييم أساس queue والتقارير
# ZILFIT Queue

Status: internal operating queue.
Purpose: asynchronous task intake for ZILFIT agents.

Rules:
- Queue files describe work to be reviewed or processed.
- Agents may read queue files and write reports.
- Agents must not modify demo, Telegram bot, proxy, auth, API keys, cron, systemd, production tunnels, or main branch.
- No file deletion.
- No commit without Sultan approval.
- Product-facing outputs must not contain medical, diagnostic, treatment, prevention, pain-relief, or clinical-efficacy claims.
- Clinical/specialist material must remain internal R&D until reviewed by qualified specialists.

Recommended flow:
1. Sultan or Z-Ops creates a queue task.
2. Cheap model reads context and prepares a report.
3. Medium/Claude model is used only for sensitive engineering, CAD/FEA, source-code edits, claims/legal, or clinical protocol refinement.
4. Output is saved under reports/daily or reports/reviews.
5. Sultan reviews before commit or operational changes.

## 7. تقييم الحدود السريرية وغير الطبية
# ZILFIT Clinical Specialist Protocol Draft

Status: internal R&D draft only.
Scope: specialist review planning, clinical validation preparation, and safety boundaries.
Public status: not clinically validated.

## 1. Purpose

This document defines how ZILFIT may prepare for future orthopedic, neurological, biomechanical, and clinical review without making public medical, diagnostic, therapeutic, or treatment claims.

The current ZILFIT work remains engineering R&D. Any medical or clinical interpretation must remain pending until reviewed by qualified specialists and supported by formal testing.

## 2. Engineering vs Clinical Boundary

Engineering validation may include:
- foot-shape estimation
- pressure-zone assumptions
- load-case assumptions
- CAD readiness checks
- FEA readiness checks
- STL/3MF printability checks
- material and wall-thickness assumptions
- prototype fit and comfort feedback

Clinical validation may include only future specialist-supervised work:
- orthopedic review
- neurological review
- gait or biomechanics review
- clinical protocol design
- safety and consent review
- supervised sample testing
- clinical outcome assessment

Engineering outputs must not be presented as clinical proof.

## 3. Specialist Reviewers Needed

Required future reviewers:
- Orthopedic specialist: foot/ankle structure, musculoskeletal safety, clinical suitability.
- Neurology specialist: sensory response, neuropathy-related exclusions, nerve-related safety concerns.
- Biomechanics reviewer: gait phase, pressure distribution, load transfer, balance, center of pressure.
- Clinical testing advisor: sample protocol, consent language, inclusion/exclusion criteria, adverse event monitoring.

## 4. What ZILFIT Agents May Prepare Before Specialist Review

Agents may prepare:
- engineering assumptions
- design-zone maps
- load-case estimates
- prototype readiness checklists
- CAD requirements
- simulation requirements
- printability checks
- non-medical risk flags
- literature summaries for specialist review
- questions for doctors and clinical reviewers

Agents may not approve clinical readiness by themselves.

## 5. What Agents Must Not Claim

Agents must not claim:
- diagnosis
- treatment
- prevention of injury or disease
- pain relief
- correction of gait pathology
- therapeutic effect
- clinical efficacy
- medical replacement for orthotics, braces, therapy, or physician care

Unsafe examples:
- "prevents plantar fasciitis"
- "reduces heel pain"
- "corrects gait abnormality"
- "treats foot pressure problems"

Allowed current framing:
- "engineering estimate"
- "design assumption"
- "pressure-zone design guidance"
- "prototype validation pending"
- "specialist review required"
- "clinical validation pending"

## 6. Proposed Future Clinical Review Checklist

Before any public clinical claim, verify:
- specialist reviewer names and credentials
- written clinical protocol
- informed consent form
- inclusion and exclusion criteria
- sample size rationale
- test environment
- measurement tools
- safety monitoring plan
- adverse event procedure
- data privacy handling
- statistical analysis plan
- final specialist sign-off

## 7. Proposed Sample Testing Workflow Before Public Launch

Phase 1: Internal engineering sample
- confirm CAD geometry
- confirm printability
- confirm basic fit
- confirm no obvious material or edge hazards

Phase 2: Supervised functional sample
- collect comfort feedback
- check fit stability
- check wear tolerance
- document failures and discomfort
- no medical claims

Phase 3: Specialist review
- orthopedic review
- neurological review if sensory or nerve-related claims are considered
- biomechanics review
- clinical testing advisor review

Phase 4: Controlled clinical validation, if approved
- specialist-approved protocol
- consented participants
- controlled measurements
- documented limitations
- independent review before public claims

## 8. Evidence Required Before Any Public Medical or Clinical Claim

Required evidence:
- completed specialist protocol
- documented test methods
- validated measurement process
- repeatable results
- safety review
- adverse event review
- specialist sign-off
- legal/claims review
- product labeling review

Until then, all outputs remain engineering-only.

## 9. Safety and Consent Notes for Private Sample Testing

Private sample testing must:
- be voluntary
- use written consent
- explain that ZILFIT is not clinically validated
- avoid diagnosis or treatment language
- allow participants to stop immediately
- record discomfort or adverse events
- exclude high-risk participants unless a clinician approves
- separate engineering feedback from clinical conclusions

## 10. Final Recommendation

Current status: internal R&D only.

ZILFIT may continue engineering validation, CAD preparation, FEA preparation, and printability checks. It should not make public medical or clinical claims until orthopedic, neurological, biomechanical, clinical, legal, and claims reviews are complete.

Next recommended work:
- keep daily cheap-model agents for reports, inventory, and non-sensitive checks
- use specialist/on-demand agents only for sample-readiness decisions
- reserve Claude/Sonnet-level model use for CAD/FEA planning, architecture decisions, source-code edits, legal-sensitive claims, and clinical protocol refinement

## 8. المخاطر
- الخلط بين التحقق الهندسي والادعاءات الطبية.
- الاعتماد على تقارير يومية سطحية بدل تدقيق هندسي عميق.
- تشغيل وكلاء متقدمين قبل وجود عينة إنتاج ملموسة.

## 9. المعوقات
- التحقق السريري غير مكتمل.
- قرارات CAD/FEA والعينات النهائية تحتاج مراجعة أقوى.

## 10. خارطة الطريق المقترحة
1. تثبيت حدود غير طبية صارمة في كل التقارير.
2. تقوية تقارير الهندسة و CAD/FEA قبل العينة.
3. تشغيل الوكلاء اليومية الرخيصة للتقارير فقط.
4. استخدام نماذج أقوى فقط للقرارات الحساسة.

## 11. التوصية النهائية
الأساس جيد كبداية تشغيلية، لكنه غير كاف بعد كمنظومة إنتاج احترافية كاملة. المطلوب الآن تقوية التدقيق الهندسي، فصل السريري عن الهندسي، وتحويل التقارير اليومية إلى نظام قرار واضح. التحقق السريري لا يزال بانتظار مراجعة متخصصين.
